165 related articles for article (PubMed ID: 31555682)
21. Induced pluripotent stem cell models of Zellweger spectrum disorder show impaired peroxisome assembly and cell type-specific lipid abnormalities.
Wang XM; Yik WY; Zhang P; Lu W; Huang N; Kim BR; Shibata D; Zitting M; Chow RH; Moser AB; Steinberg SJ; Hacia JG
Stem Cell Res Ther; 2015 Aug; 6():158. PubMed ID: 26319495
[TBL] [Abstract][Full Text] [Related]
22.
Benson MD; Papp KM; Casey GA; Radziwon A; St Laurent CD; Doucette LP; MacDonald IM
Ophthalmol Sci; 2021 Jun; 1(2):100028. PubMed ID: 36249295
[TBL] [Abstract][Full Text] [Related]
23. Characterization of Severity in Zellweger Spectrum Disorder by Clinical Findings: A Scoping Review, Meta-Analysis and Medical Chart Review.
Bose M; Yergeau C; D'Souza Y; Cuthbertson DD; Lopez MJ; Smolen AK; Braverman NE
Cells; 2022 Jun; 11(12):. PubMed ID: 35741019
[TBL] [Abstract][Full Text] [Related]
24. Mild Zellweger syndrome due to functionally confirmed novel PEX1 variants.
Lipiński P; Stawiński P; Rydzanicz M; Wypchło M; Płoski R; Stradomska TJ; Jurkiewicz E; Ferdinandusse S; Wanders RJA; Vaz FM; Tylki-Szymańska A
J Appl Genet; 2020 Feb; 61(1):87-91. PubMed ID: 31628608
[TBL] [Abstract][Full Text] [Related]
25. Clinical, neuroradiological, and molecular characterization of patients with atypical Zellweger spectrum disorder caused by PEX16 mutations: a case series.
Cheung A; Argyriou C; Yergeau C; D'Souza Y; Riou É; Lévesque S; Raymond G; Daba M; Rtskhiladze I; Tkemaladze T; Adang L; La Piana R; Bernard G; Braverman N
Neurogenetics; 2022 Apr; 23(2):115-127. PubMed ID: 35106698
[TBL] [Abstract][Full Text] [Related]
26. It's Never Too Late for a Diagnosis.
Coelho M; Durães J; Freixo J; Tomás J; Macário C
Endocr Metab Immune Disord Drug Targets; 2023 Oct; ():. PubMed ID: 37859411
[TBL] [Abstract][Full Text] [Related]
27. Temperature-sensitive mutation of PEX6 in peroxisome biogenesis disorders in complementation group C (CG-C): comparative study of PEX6 and PEX1.
Imamura A; Shimozawa N; Suzuki Y; Zhang Z; Tsukamoto T; Fujiki Y; Orii T; Osumi T; Wanders RJ; Kondo N
Pediatr Res; 2000 Oct; 48(4):541-5. PubMed ID: 11004248
[TBL] [Abstract][Full Text] [Related]
28. Spectrum of PEX6 mutations in Zellweger syndrome spectrum patients.
Ebberink MS; Kofster J; Wanders RJ; Waterham HR
Hum Mutat; 2010 Jan; 31(1):E1058-70. PubMed ID: 19877282
[TBL] [Abstract][Full Text] [Related]
29. Chinese patients with adrenoleukodystrophy and Zellweger spectrum disorder presenting with hereditary spastic paraplegia.
Chen YJ; Wang MW; Dong EL; Lin XH; Wang N; Zhang ZQ; Lin X; Chen WJ
Parkinsonism Relat Disord; 2019 Aug; 65():256-260. PubMed ID: 31227335
[TBL] [Abstract][Full Text] [Related]
30. Heimler Syndrome Is Caused by Hypomorphic Mutations in the Peroxisome-Biogenesis Genes PEX1 and PEX6.
Ratbi I; Falkenberg KD; Sommen M; Al-Sheqaih N; Guaoua S; Vandeweyer G; Urquhart JE; Chandler KE; Williams SG; Roberts NA; El Alloussi M; Black GC; Ferdinandusse S; Ramdi H; Heimler A; Fryer A; Lynch SA; Cooper N; Ong KR; Smith CE; Inglehearn CF; Mighell AJ; Elcock C; Poulter JA; Tischkowitz M; Davies SJ; Sefiani A; Mironov AA; Newman WG; Waterham HR; Van Camp G
Am J Hum Genet; 2015 Oct; 97(4):535-45. PubMed ID: 26387595
[TBL] [Abstract][Full Text] [Related]
31. The PEX Gene Screen: molecular diagnosis of peroxisome biogenesis disorders in the Zellweger syndrome spectrum.
Steinberg S; Chen L; Wei L; Moser A; Moser H; Cutting G; Braverman N
Mol Genet Metab; 2004 Nov; 83(3):252-63. PubMed ID: 15542397
[TBL] [Abstract][Full Text] [Related]
32. Allogeneic Hematopoietic Stem Cell Transplantation for PEX1-Related Zellweger Spectrum Disorder: A Case Report and Literature Review.
Chen K; Zhang N; Shao JB; Li H; Li J; Xi JM; Xu WH; Jiang H
Front Pediatr; 2021; 9():672187. PubMed ID: 34513757
[TBL] [Abstract][Full Text] [Related]
33. The Pex1-G844D mouse: a model for mild human Zellweger spectrum disorder.
Hiebler S; Masuda T; Hacia JG; Moser AB; Faust PL; Liu A; Chowdhury N; Huang N; Lauer A; Bennett J; Watkins PA; Zack DJ; Braverman NE; Raymond GV; Steinberg SJ
Mol Genet Metab; 2014 Apr; 111(4):522-532. PubMed ID: 24503136
[TBL] [Abstract][Full Text] [Related]
34. Histologic and ultrastructural features in early and advanced phases of Zellweger spectrum disorder (infantile Refsum disease).
Warren M; Mierau G; Wartchow EP; Shimada H; Yano S
Ultrastruct Pathol; 2018; 42(3):220-227. PubMed ID: 29482424
[TBL] [Abstract][Full Text] [Related]
35. Carrier frequency estimation of Zellweger spectrum disorder using ExAC database and bioinformatics tools.
Vasiljevic E; Ye Z; Pavelec DM; Darst BF; Engelman CD; Baker MW
Genet Med; 2019 Sep; 21(9):1969-1976. PubMed ID: 30846882
[TBL] [Abstract][Full Text] [Related]
36. A Chinese newborn with Zellweger syndrome and compound heterozygous mutations novel in the
Lu P; Ma L; Sun J; Gong X; Cai C
Transl Pediatr; 2021 Feb; 10(2):446-453. PubMed ID: 33708531
[TBL] [Abstract][Full Text] [Related]
37. Autosomal dominant Zellweger spectrum disorder caused by de novo variants in PEX14 gene.
Waterham HR; Koster J; Ebberink MS; Ješina P; Zeman J; Nosková L; Kmoch S; Devic P; Cheillan D; Wanders RJA; Ferdinandusse S
Genet Med; 2023 Nov; 25(11):100944. PubMed ID: 37493040
[TBL] [Abstract][Full Text] [Related]
38. Genotype-phenotype correlations and disease mechanisms in PEX13-related Zellweger spectrum disorders.
Borgia P; Baldassari S; Pedemonte N; Alkhunaizi E; D'Onofrio G; Tortora D; Calì E; Scudieri P; Balagura G; Musante I; Diana MC; Pedemonte M; Vari MS; Iacomino M; Riva A; Chimenz R; Mangano GD; Mohammadi MH; Toosi MB; Ashrafzadeh F; Imannezhad S; Karimiani EG; Accogli A; Schiaffino MC; Maghnie M; Soler MA; Echiverri K; Abrams CK; Striano P; Fortuna S; Maroofian R; Houlden H; Zara F; Fiorillo C; Salpietro V
Orphanet J Rare Dis; 2022 Jul; 17(1):286. PubMed ID: 35854306
[TBL] [Abstract][Full Text] [Related]
39. Identification of novel mutations in PEX2, PEX6, PEX10, PEX12, and PEX13 in Zellweger spectrum patients.
Krause C; Rosewich H; Thanos M; Gärtner J
Hum Mutat; 2006 Nov; 27(11):1157. PubMed ID: 17041890
[TBL] [Abstract][Full Text] [Related]
40. Liver disease predominates in a mouse model for mild human Zellweger spectrum disorder.
Berendse K; Boek M; Gijbels M; Van der Wel NN; Klouwer FC; van den Bergh-Weerman MA; Shinde AB; Ofman R; Poll-The BT; Houten SM; Baes M; Wanders RJA; Waterham HR
Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2774-2787. PubMed ID: 31207289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
